GRP
PVLA

Global Retirement Partners’s Palvella Therapeutics PVLA Stock Holding History

Global Retirement Partners’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.93K Buy
+28
New +$2.39K ﹤0.01% 3607

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Global Retirement Partners's PVLA Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Palvella Therapeutics (PVLA) in Q4 2025: 28 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #3607 among its holdings.

140 funds tracked by Wall St. Rank hold PVLA as of Q4 2025.

  • Global Retirement Partners held 28 shares of Palvella Therapeutics worth $2.93K as of Q4 2025.
  • Palvella Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Palvella Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3607 holding.
  • 140 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.